Detail akcie LifeMD Rg online

Business Summary: LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, LifeMD Inc revenues increased 27% to $188.1M. Net loss applicable to common stockholders decreased 67% to $6.8M. Revenues reflect Telehealth segment increase of 37% to $148.3M, WorkSimpli segment increase of less than 1% to $39.8M. Lower net loss reflects Telehealth segment loss decrease of 68% to $5.5M, WorkSimpli segment income increase from $343K to $5.1M.